American Board of Radiology (ABR) · Verified against the ABR Radiation Oncology Remote Oral Certifying Exam Guide, 2026, revised July 8, 2026, and the currently linked Radiation Oncology Study Guide: Oral Exam. The generic workbook label is mapped to the ABR Oral Certifying Exam, preserving the assigned slug. The linked study guide has '2023' in its filename but no printed revision or effective date; it lists eight clinical categories without percentage weights. July 8, 2026 is the administration handbook revision date, not an established content-blueprint effective date.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Get Certified in Radiation Oncology (RO)
• Radiation Oncology Remote Oral Certifying Exam Guide — 2026
• Radiation Oncology Study Guide: Oral Exam
• Rectal Cancer Treatment (PDQ®)–Health Professional Version
• Anal Cancer Treatment (PDQ®)–Health Professional Version
• Esophageal Cancer Treatment (PDQ®)–Health Professional Version
• Cervical Cancer Treatment (PDQ®)–Health Professional Version
• Endometrial Cancer Treatment (PDQ®)–Health Professional Version
• Prostate Cancer Treatment (PDQ®)–Health Professional Version
• Bladder Cancer Treatment (PDQ®)–Health Professional Version
• Testicular Cancer Treatment (PDQ®)–Health Professional Version
• Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version
• Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Health Professional Version
• Oropharyngeal Cancer Treatment (PDQ®)–Health Professional Version
• Evidence-based Guideline: Diagnosis, Treatment, Prevention and Aftercare of Oropharyngeal and Hypopharyngeal Carcinoma — Long Version 1.0, February 2024
• Skin Cancer Treatment (PDQ®)–Health Professional Version
• Breast Cancer Treatment (PDQ®)–Health Professional Version
• Specification and Acceptance Testing of Radiotherapy Treatment Planning Systems — IAEA-TECDOC-1540
• ECRI Guidelines Trust: Radiation Therapy for Brain Metastases — ASTRO Guideline Profile
• Central Nervous System Tumors Treatment (PDQ®)–Health Professional Version
• NRG Oncology Trial Shows Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastases Reduces Risks of Cognitive Toxicity and Neurologic Symptoms
• Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®)–Health Professional Version
• Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version
• Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version
• EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer — Disease Management
• EAU Guidelines on Testicular Cancer — Diagnostic Evaluation
• EAU Guidelines on Prostate Cancer — Treatment
• Preoperative versus Postoperative Radiotherapy in Soft-tissue Sarcoma of the Limbs: A Randomised Trial
• ASTRO Issues Patient-centered Clinical Guideline on Partial Breast Irradiation for Early-stage Invasive Breast Cancer and DCIS
• Radiation Oncology (RO) Exam Dates
• ASTRO Guideline on Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin
• Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline
• Cardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk
• Client Challenge
• Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline - PMC
• FDA approves osimertinib for locally advanced, unresectable (stage III) non-small cell lung cancer following chemoradiation therapy | FDA
• Durvalumab - NCI
• Get Certified in Radiation Oncology (RO) - American Board of Radiology
• ESMO_2023_GynaecologicalCancers.pdf
• RAPID_TRIAL_EARLY_STAGE-nejmoa1408648.pdf
• IMWG Criteria for the Diagnosis of MM | Inl Myeloma Fn
• GGPO_Oropharyngeal_and_Hypopharyngeal_Carcinoma_Version_1.0.pdf
• asbrs-accelerated-partial-breast-irradiation.pdf